This Trade Risks Less Than $50 for a Potential Gain of 300%
 | You're receiving this email because you are subscribed to Options Profits Daily,
if you no longer wish to receive these emails you can unsubscribe here. | |  | |
 | | This Trade Risks Less Than $50 for a Potential Gain of 300% | | | Over the course of years, a new drug could move a stock by several hundred percent. That's why news about drug approval is important for investors to consider.
In our latest article, we share the details of a drug approval process that could set up a triple digit gain for investors.
Based on actual recent market data, we highlight a trade with tremendous potential. The trade is based on the potential movement of the stock of a company that recently received news that the U.S. Food and Drug Administration granted fast-track designation for its investigational Zika vaccine.
This trade could result in a gain of 300% based on recent market data which we share with you. The total risk on the trade is $50, again based on data that we share with you.
Some investors may avoid high risk stocks, and any biotech stock is a high-risk trade, while the company is in the development and approval process. Investors may avoid these stocks because they may lack the capital to build a diversified position in this type of stock.
However, as we explain in the article, there are strategies that lower the capital required to trade these stocks.
We explain in detail, one such options strategy. This strategy is one that is focused on risk and is able to limit the risk to a precise level in dollar terms. In this trade, the risk is limited to $50 based on recent market prices.
You can find all of the details of the strategy and the specific trade in our latest free educational article that is available right here.
| | YOU PROBABLY MISSED THIS: |  | | | | ` | |
Not sure the best way to get started?
Follow these simple steps to hit the ground running. | |
Nothing in this email should be considered personalized financial advice. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing The Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
As defined in the United States Securities Act of 1933 Section 27(a), as amended in the Securities Exchange Act of 1934 Section 21(e), statements in this communication which are not purely historical are forward-looking statements and include statements regarding beliefs, plans, intent, predictions or other statements of future tense.
Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.
| | |
No comments:
Post a Comment